NCT03329950 2024-03-28A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced MalignanciesCelldex TherapeuticsPhase 1 Completed132 enrolled
NCT03602079 2023-08-03Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 GeneKlus Pharma Inc.Phase 1/2 Completed49 enrolled
NCT00743262 2023-07-25Short-term Clinical Feasibility of the New Provox Vega 22.5 Voice ProsthesisAtos Medical ABPhase 1/2 Completed15 enrolled 7 charts
NCT01045057 2021-06-11Clinical Feasibility of New Tracheoesophageal Puncture SetAtos Medical ABPhase NA Completed27 enrolled 9 charts